![学納金サイト [在学生・保護者専用]](/assets/images/BlkFeatured_item_tuition.jpg)
Faculty of Medicine教員紹介：片岡 恵子
| 氏名 |
片岡 恵子
カタオカ ケイコ KATAOKA, Keiko |
|---|---|
| 職位 | 准教授 |
| 学内の役職・委員等 | 医局長 |
| 所属教室 | |
| 専攻・専門分野（大学院） |
医学専攻 眼科学分野（新課程） 外科系専攻 眼科学分野（旧課程） |
| 専門分野 | 網膜硝子体、黄斑疾患 |
| 研究テーマ | 加齢黄斑変性、近視性黄斑症等黄斑疾患を対象とした画像解析による病態解明および新規治療法の開発 |
| 略歴 | 2005年 名古屋大学医学部 卒業 2007年 名古屋大学眼科 入局 2011年 名古屋大学大学院博士課程 修了 2012年 Massachusetts Eye and Ear リサーチフェロー 2015年 名古屋大学医学部附属病院 眼科 助教 2020年10月名古屋大学医学部附属病院 眼科 病院講師 2021年1月杏林大学医学部 眼科学教室 講師 2024年4月杏林大学医学部眼科学教室 准教授 現在に至る |
| 所有する学位 | 博士（医学） |
| 指導医・専門医・認定医、その他の資格等 | 日本眼科専門医 眼科PDT認定医 |
| 論文・著書等を含む主要研究業績 |
1. Kataoka K, Itagaki K, Hashiya N, Wakugawa S, Tanaka K, Nakayama M, Yamamoto A, Mukai R, Honjyo J, Maruko I, Kawai M, Miyara Y, Terao N, Wakatsuki Y, Onoe H, Mori R, Koizumi H, Sekiryu T, Iida T, Okada AA; for Japan AMD Research Consortium (JARC).: Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2024 Jan;262(1):43-51. 2. Mukai R, Kataoka K, Tanaka K, Miyara Y, Maruko I, Nakayama M, Watanabe Y, Yamamoto A, Wakatsuki Y, Onoe H, Wakugawa S, Terao N, Hasegawa T, Hashiya N, Kawai M, Maruko R, Itagaki K, Honjo J, Okada AA, Mori R, Koizumi H, Iida T, Sekiryu T.: Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in Japan. Sci Rep. 2023 May 30;13(1):8747. 3. Takeuchi J, Ota H, Nakano Y, Horiguchi E, Taki Y, Ito Y, Terasaki H, Nishiguchi KM, Kataoka K.: Predictive factors for outcomes of half-dose photodynamic therapy combined with aflibercept for pachychoroid neovasculopathy. Graefes Arch Clin Exp Ophthalmol. 2023 Aug;261(8):2235-2243. 4. Nakano Y, Takeuchi J, Horiguchi E, Ota H, Taki Y, Ito Y, Terasaki H, Nishiguchi KM, Kataoka K.: LONG-TERM MORPHOLOGIC CHANGES IN MACULAR NEOVASCULARIZATION UNDER AFLIBERCEPT TREATMENT WITH A TREAT-AND-EXTEND REGIMEN. Retina. 2023 Mar 1;43(3):412-419. 5. Nakamura K, Takeuchi J, Kataoka K, Ota H, Asai K, Nakano Y, Horiguchi E, Taki Y, Ito Y, Terasaki H, Nishiguchi KM.: EFFECTS OF HALF-DOSE PHOTODYNAMIC THERAPY ON CHRONIC CENTRAL SEROUS CHORIORETINOPATHY WITH OR WITHOUT MACULAR NEOVASCULARIZATION ASSESSED USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Retina. 2022 Dec 1;42(12):2346-2353. 6. Taki Y, Ito Y, Takeuchi J, Ito H, Nakano Y, Sajiki AF, Horiguchi E, Ota H, Kataoka K, Terasaki H.: Displacement of the retina and changes in the foveal avascular zone area after internal limiting membrane peeling for epiretinal membrane. Jpn J Ophthalmol. 2023 Jan;67(1):74-83. 7. Horiguchi E, Takeuchi J, Tomita R, Asai K, Nakano Y, Ota H, Taki Y, Ito Y, Terasaki H, Nishiguchi KM, Kataoka K.: Choroidal hemodynamics in central serous chorioretinopathy after half-dose photodynamic therapy and the effects of smoking. Sci Rep. 2022 Oct 11;12(1):17032. 8. Tanaka K, Koizumi H, Tamashiro T, Itagaki K, Nakayama M, Maruko I, Wakugawa S, Terao N, Onoe H, Wakatsuki Y, Kasai A, Ogasawara M, Shintake H, Sugano Y, Yamamoto A, Kataoka K, Hasegawa T, Izumi T, Kawai M, Maruko R, Sekiryu T, Okada AA, Iida T, Mori R.: Short-term results for brolucizumab in treatment-naïve neovascular age-related macular degeneration: a Japanese multicenter study. Jpn J Ophthalmol. 2022 Jul;66(4):379-385. 9. Ota H, Takeuchi J, Nakano Y, Horiguchi E, Taki Y, Ito Y, Terasaki H, Nishiguchi KM, Kataoka K.: Switching from aflibercept to brolucizumab for the treatment of refractory neovascular age-related macular degeneration. Jpn J Ophthalmol. 2022 May;66(3):278-284. 10. Tamashiro T, Tanaka K, Itagaki K, Nakayama M, Maruko I, Wakugawa S, Terao N, Onoe H, Wakatsuki Y, Ogasawara M, Sugano Y, Yamamoto A, Kataoka K, Izumi T, Kawai M, Mori R, Sekiryu T, Okada AA, Iida T, Koizumi H; Japan AMD Research Consortium (JARC).: Subfoveal choroidal thickness after brolucizumab therapy for neovascular age-related macular degeneration: a short-term multicenter study. Graefes Arch Clin Exp Ophthalmol. 2022 Jun;260(6):1857-1865. 11. Ito Y, Ito M, Iwase T, Kataoka K, Yamada K, Yasuda S, Ito H, Takeuchi J, Nakano Y, Fujita A, Horiguchi E, Taki Y, Yatsuya H, Terasaki H.: Prevalence of and factors associated with dilated choroidal vessels beneath the retinal pigment epithelium among the Japanese. Sci Rep. 2021 May 28;11(1):11278. 12. Ito H, Ito Y, Kataoka K, Ueno S, Takeuchi J, Nakano Y, Fujita A, Horiguchi E, Kaneko H, Iwase T, Terasaki H.: Erratum to Association Between Retinal Layer Thickness and Perfusion Status in Extramacular Areas in Diabetic Retinopathy. Am J Ophthalmol 2020; 215:25-36. Am J Ophthalmol. 2021 Apr 13:S0002-9394(20)30675-9. 13. Fujita A, Kataoka K, Takeuchi J, Nakano Y, Horiguchi E, Kaneko H, Ito Y, Terasaki H.: Reply. Retina. 2021 Sep 1;41(9):e54. 14. Suwa S, Tomita R, Kataoka K, Ueno S.: Development of Vogt-Koyanagi-Harada Disease-like Uveitis during Treatment by Anti-programmed Death Ligand-1 Antibody for Non-small Cell Lung Cancer: A Case Report. Ocul Immunol Inflamm. 2022 Aug;30(6):1522-1526. 15. Takashi N, Nakamura A, Kataoka K, Usui Y, Ito Y, Kaneko H.: Optical coherence tomography angiography for the diagnosis of granulomatosis with polyangiitis with serous retinal detachment: A case report. Medicine (Baltimore). 2021 Feb 19;100(7):e24789. 16. Kataoka K, Horiguchi E, Kawano K, Ushida H, Nakano Y, Ito Y, Terasaki H.: Three cases of brolucizumab-associated retinal vasculitis treated with systemic and local steroid therapy. Jpn J Ophthalmol. 2021 Mar;65(2):199-207. 17. Kaneko H, Hirata N, Shimizu H, Kataoka K, Nonobe N, Mokuno K, Terasaki H.: Effect of internal limiting membrane peeling on visual field sensitivity in eyes with epiretinal membrane accompanied by glaucoma with hemifield defect and myopia. Jpn J Ophthalmol. 2021 May;65(3):380-387. 18. Funahashi S, Ito Y, Kataoka K, Takeuchi J, Nakano Y, Fujita A, Horiguchi E, Taki Y, Terasaki H.: Spontaneous closure of macular hole after vitrectomy for myopic retinoschisis with foveal detachment. Retin Cases Brief Rep. 2021 Jan 18. 19. Tsunekawa Y, Kataoka K, Asai K, Ito Y, Terasaki H.: Four-year outcome of aflibercept administration using a treat-and-extend regimen in eyes with recurrent neovascular age-related macular degeneration. Jpn J Ophthalmol. 2021 Jan;65(1):69-76. 20. Takeuchi J, Kataoka K, Shimizu H, Tomita R, Kominami T, Ushida H, Kaneko H, Ito Y, Terasaki H.: INTRAOPERATIVE AND POSTOPERATIVE MONITORING OF AUTOLOGOUS NEUROSENSORY RETINAL FLAP TRANSPLANTATION FOR A REFRACTORY MACULAR HOLE ASSOCIATED WITH HIGH MYOPIA. Retina. 2021 May 1;41(5):921-930. 21. Shimizu H, Yamada K, Suzumura A, Kataoka K, Takayama K, Sugimoto M, Terasaki H, Kaneko H: Caveolin-1 Promotes Cellular Senescence in Exchange for Blocking Subretinal Fibrosis in Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2020 Sep 1;61(11):21. 22. Ito H, Ito Y, Kataoka K, Ueno S, Takeuchi J, Nakano Y, Fujita A, Horiguchi E, Kaneko H, Iwase T, Terasaki H: Association Between Retinal Layer Thickness and Perfusion Status in Extramacular Areas in Diabetic Retinopathy. Am J Ophthalmol. 2020 Jul;215:25-36. 23. Ito Y, Ito M, Ueno S, Kataoka K, Takeuchi J, Kominami T, Takayama K, Terasaki H: Changes in intraocular pressure and aqueous flare in eyes with multiple evanescent white dot syndrome. Jpn J Ophthalmol. 2020 Jul;64(4):378-384. 24. Matsuura T, Kaneko H, Takayama K, Shibata R, Kataoka K, Ito S, Tsunekawa T, Shimizu H, Suzumura A, Namba R, Ito Y, Murohara T, Terasaki H: Diacron reactive oxygen metabolites and biological antioxidant potential tests for patients with age-related macular degeneration. BMC Ophthalmol. 2020 Feb 18;20(1):56. 25. Minami S, Ito Y, Ueno S, Kataoka K, Takeuchi J, Ito H, Nakano Y, Kitagawa M, Leahy C, Straub J, Terasaki H: Analysis of macular curvature in normal eyes using swept-source optical coherence tomography. Jpn J Ophthalmol. 2020 Mar;64(2):180-186. 26. Suzumura A, Kaneko H, Funahashi Y, Takayama K, Nagaya M, Ito S, Okuno T, Hirakata T, Nonobe N, Kataoka K, Shimizu H, Namba R, Yamada K, Ye F, Ozawa Y, Yokomizo T, Terasaki H: n-3 Fatty Acid and Its Metabolite 18-HEPE Ameliorate Retinal Neuronal Cell Dysfunction by Enhancing Müller BDNF in Diabetic Retinopathy. Diabetes. 2020 Apr;69(4):724-735. 27. Fujita A, Kataoka K, Takeuchi J, Nakano Y, Horiguchi E, Kaneko H, Ito Y, Terasaki H: DIAGNOSTIC CHARACTERISTICS OF POLYPOIDAL CHOROIDAL VASCULOPATHY BASED ON B-SCAN SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY AND ITS INTERRATER AGREEMENT COMPARED WITH INDOCYANINE GREEN ANGIOGRAPHY. Retina. 2020 Dec;40(12):2296-2303. 28. Namba R, Kaneko H, Suzumura A, Shimizu H, Kataoka K, Takayama K, Yamada K, Funahashi Y, Ito S, Nonobe N, Terasaki H: In Vitro Epiretinal Membrane Model and Antibody Permeability: Relationship With Anti-VEGF Resistance in Diabetic Macular Edema. Invest Ophthalmol Vis Sci. 2019 Jul 1;60(8):2942-2949. 29. Nakano Y, Kataoka K, Takeuchi J, Fujita A, Kaneko H, Shimizu H, Ito Y, Terasaki H: Vascular maturity of type 1 and type 2 choroidal neovascularization evaluated by optical coherence tomography angiography. PLoS One. 2019 Apr 29;14(4):e0216304. 30. Shimizu H, Kaneko H, Suzumura A, Takayama K, Namba R, Funahashi Y, Kataoka K, Iwase T, Hwang SJ, Ito S, Yamada K, Ueno S, Ito Y, Terasaki H: Biological Characteristics of Subsilicone Oil Fluid and Differences With Other Ocular Humors. Transl Vis Sci Technol. 2019 Feb 28;8(1):28. 31. Tsoka P, Barbisan PR, Kataoka K, Chen XN, Tian B, Bouzika P, Miller JW, Paschalis EI, Vavvas DG: NLRP3 inflammasome in NMDA-induced retinal excitotoxicity. Exp Eye Res. 2019 Apr;181:136-144. 32. Yamada K, Kaneko H, Tsunekawa T, Shimizu H, Suzumura A, Namba R, Takeuchi J, Kataoka K, Takayama K, Inoue M, Ito Y, Terasaki H: Silicone oil-associated retinal light exposure under a surgical microscope. Acta Ophthalmol. 2019 Aug;97(5):e742-e746. |
| 所属学会 |
日本眼科学会 網膜硝子体学会 眼循環学会 |